Distinct requirements for Ras oncogenesis in human versus mouse cells
Nesrin M Hamad(Duke University), Christopher M. Counter(Duke University)
Cited by 422
Related Papers
Tumour maintenance is mediated by eNOS
|Nature|2008|320
Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability
|Nature Communications|2018|91
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution
|Cell Reports|2017|86
Rare codons capacitate Kras-driven de novo tumorigenesis
|Journal of Clinical Investigation|2014|78
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|Nature Communications|2017|46